MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 34 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,001 | -12.4% | 645,490 | -19.4% | 0.00% | 0.0% |
| Q2 2023 | $2,283 | -31.6% | 800,776 | -5.4% | 0.00% | -50.0% |
| Q1 2023 | $3,336 | +31.3% | 846,828 | +32.0% | 0.00% | +100.0% |
| Q4 2022 | $2,540 | -99.9% | 641,353 | +18.6% | 0.00% | -80.0% |
| Q3 2022 | $4,968,000 | +281.6% | 540,582 | +155.3% | 0.01% | +400.0% |
| Q2 2022 | $1,302,000 | -10.5% | 211,710 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $1,455,000 | -45.3% | 226,710 | -44.2% | 0.00% | – |
| Q4 2021 | $2,658,000 | +131.9% | 406,026 | +102.3% | 0.00% | -100.0% |
| Q3 2021 | $1,146,000 | +2.2% | 200,688 | -1.6% | 0.00% | 0.0% |
| Q2 2021 | $1,121,000 | +23.3% | 203,901 | +30.0% | 0.00% | – |
| Q1 2021 | $909,000 | +263.6% | 156,876 | +320.4% | 0.00% | – |
| Q4 2020 | $250,000 | -8.4% | 37,315 | 0.0% | 0.00% | – |
| Q3 2020 | $273,000 | +93.6% | 37,315 | 0.0% | 0.00% | – |
| Q2 2020 | $141,000 | – | 37,315 | +76053.1% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 49 | -94.6% | 0.00% | – |
| Q4 2019 | $14,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |